PlainRecalls

Astellas Pharma US Inc.

Compiled from official public sources by the publisher.

5 recalls on record · Latest: Feb 5, 2025

Subscribe to new Astellas Pharma US Inc. recalls (RSS)

Agency notice ledger

Federal filing book Astellas Pharma US Inc. LIGHT-BOOK · SINGLE-AGENCY

#2,367 of 14,151 · 5 notices · 0.005% archive

  • BOOK 5 notices
  • RANK #2,367 of 14,151
  • SHARE 0.005% archive
  • AGENCY FDA Drug (5)
  • CAT drugs
  • CATS 2 categories
  • LATEST Feb 5, 2025
  • PHOTO A G Specialty Foods I…

Nearest notice-volume peer: A G Specialty Foods Inc (0 notice gap)

Astellas Pharma US Inc. accounts for about 0.005% of the 104,423-notice archive on 5 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Astellas Pharma US Inc. sits among 14,151 recalling firms

Astellas Pharma US Inc. ranks 2,367th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Astellas Pharma US Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

5 2367th of 14151 higher than 11,411 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Astellas Pharma US Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Astellas Pharma US Inc. holds about 0.005% of archive notices alongside 5 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Critical Feb 5, 2025

Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.
FDA Drug Critical Feb 5, 2025

Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.
FDA Drug Moderate Feb 14, 2018

Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by: Astellas Pharma US, Inc. Northbrook, IL 60062, NDC 0469-3211-10
FDA Drug Moderate Oct 15, 2014

Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01
FDA Drug Moderate Jul 31, 2013

AmBisome (amphotericin B) liposome for injection, 50mg vial, single use vial, For Intravenous Infusion Only, Rx Only, Marketed by: Astellas Pharma US, Inc., Northbrook, IL 60062, Manufactured by: Gilead Sciences, Inc, San Dimas, CA 91773, NDC: 0469-3051-30.

Astellas Pharma US Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Apace Ky LLC 5 AstraZeneca Pharmaceuticals LP 5 Atlantic Management Resources Ltd. 5 Avkare Incorporated 5

Frequently Asked Questions

How many federal recall notices name Astellas Pharma US Inc.? ▼
PlainRecalls indexes 5 distinct federal recall events naming Astellas Pharma US Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Astellas Pharma US Inc. sit among other recalling firms? ▼
Astellas Pharma US Inc. ranks #2,367 of 14,151 by distinct recall-event count among 14,151 firms in this archive (81st percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Astellas Pharma US Inc.'s notices? ▼
FDA Drug accounts for 5 of this firm's 5 indexed notices.
What product category dominates Astellas Pharma US Inc.'s filing book? ▼
Filings for Astellas Pharma US Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Astellas Pharma US Inc.: 5 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Astellas Pharma US Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026